Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.
about
Advances in Proteomic Techniques for Cytokine Analysis: Focus on Melanoma Research.Myeloid-derived suppressor cells coming of age.Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studiesMiR-486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
P2860
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@ast
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@en
type
label
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@ast
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@en
prefLabel
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@ast
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@en
P2093
P2860
P356
P1433
P1476
Ipilimumab treatment decreases ...... vivors with advanced melanoma.
@en
P2093
Giuseppe V Masucci
Isabel Poschke
Johan Hansson
Maria Nyström
Maria Wolodarski
Rolf Kiessling
Suzanne Eghyazi Brage
Ulrika Edbäck
Yuya Yoshimoto
P2860
P304
21539-21553
P356
10.18632/ONCOTARGET.15368
P407
P577
2017-03-01T00:00:00Z